Top of page
Global Site Navigation

School of Medical and Health Sciences

Local Section Navigation
You are here: Main Content

Dr Carlos Aya-Bonilla

Dr Carlos Aya-Bonilla is a Post Doctoral Fellow in the School of Medical and Health Sciences.


  • Doctor of Philosophy, Griffith University, 2013.


Recent Research Grants

  • Enabling Advanced Single Cell Cancer Genomics in Western Australia,  Cancer Research Trust,  The Grant,  2017 - 2022,  $305,925.
  • Single Cell Whole Transcriptome Sequencing of Melanoma Circulating Tumour Cells (CTCs): Unveiling Cell Diversity,  Tour de Cure,  Pioneering Cancer Research Grant,  2019,  $120,000.
  • Blood Based Biomarkers Predictive of Treatment Response in Melanoma,  Cancer Council of WA Inc,  Grant,  2016 - 2018,  $246,822.
  • Circulating Tumour Cells (CTCs) as biomarkers in metastatic melanoma,  Edith Cowan University,  ECU Early Career Researcher Grant - 2016,  2016 - 2017,  $30,000.
  • Gene expression profiling of circulating tumour cells (CTCs) isolated from metastatic melanoma patients using a microfluidic chip,  Cancer Council of WA Inc,  Grant - Early Career Investigator,  2016 - 2017,  $35,000.
  • Transcriptomic profiling of Circulating Tumour Cells (CTCs) isolated from metastatic melanoma patients,  Edith Cowan University,  School of Medical and Health Sciences Research Grant Scheme 2016,  2016,  $10,000.

Recent Publications (within the last five years)

Journal Articles

  • Aya-Bonilla, C., Gray, E., Manikandan, J., Freeman, J., Zaenker, P., Reid, A., Khattak, M., Frank, M., Millward, M., Ziman, M., (2019), Immunomagnetic-Enriched Subpopulations of Melanoma Circulating Tumour Cells (CTCs) Exhibit Distinct Transcriptome Profiles. Cancers, 11(157), 15p., DOI: 10.3390/cancers11020157.
  • Marsavela, G., Aya-Bonilla, C., Warkiani, M., Gray, E., Ziman, M., (2018), Melanoma circulating tumor cells: Benefits and challenges required for clinical application. Cancer Letters, 424(Jun 2018), 1-8, Ireland, Elsevier, DOI: 10.1016/j.canlet.2018.03.013.
  • Aya-Bonilla, C., Marsavela, G., Freeman, J., Lomma, C., Frank, M., Khattak, M., Tarek, M., Millward, M., Warkiani, M., Gray, E., Ziman, M., (2017), Isolation and detection of circulating tumour cells from metastatic melanoma patients using a slanted spiral microfluidic device. Oncotarget, 8(40), 67355-67368, New York, USA, Impact Journals LLC, DOI: 10.18632/oncotarget.18641.
  • Aya-Bonilla, C., Torres, J., Muskus, C., Gaviria, GR., Sierra, JC., Sanchez, MS., Cuéllar-Ambrosi, F., Garcés, JH., Artigas, CG., Muñetón, CM., Palacio, GV., (2014), Detection of p190BCR-ABL and p210B CR-ABL fusion transcripts in patients with chronic myeloid leukemia (CML) using qualitative RT-PCR [Frecuencia de los transcriptos p190BCR-ABL y p210BCR-ABL en una población colombiana con leucemia mieloide crónica (LMC) usando RT-PCR cualitativa]. Iatreia: revista medica Universidad de Antioquia, 27(4), 398-409, Universidad de Antioquia.
  • Aya-Bonilla, C., Camilleri, E., Haupt, L., Lea, R., Gandhi, M., Griffiths, L., (2014), In silico analyses reveal common cellular pathways affected by loss of heterozygosity (LOH) events in the lymphomagenesis of Non-Hodgkin's lymphoma (NHL). BMC Genomics, 15(1), Article number 390, BioMed Central, DOI: 10.1186/1471-2164-15-390.
  • Aya-Bonilla, C., Camilleri, E., Benton, M., Haupt, L., Marlton, P., Lea, R., Gandhi, M., Griffiths, L., (2014), Fine mapping of the 15q21 region implicates TP53BP1 and B2M in the lymphomagenesis of follicular and diffuse large B-cell lymphomas. Journal of Carcinogenesis & Mutagenesis, 5(6), Article no. 195, Westlake, USA, Omics Publishing Group, DOI: 10.4172/2157-2518.1000195.

Research Student Supervision

Associate Supervisor

Skip to top of page